Delivery Order SPE2DR25D3016-SPE2DR26FG3ZB
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,734.09 to AmerisourceBergen Drug Corp for Adderall XR 20 mg capsules (quantity: 100s) on November 7, 2025, with an ultimate completion date of November 10, 2025. The contract employs firm fixed-price pricing and carries no set-aside designation, indicating it was competitively awarded. The place of performance is listed as Conshohocken, Pennsylvania, which is also the location of AmerisourceBergen's corporate headquarters,...
- The Defense Logistics Agency awarded a delivery order valued at $1,734.12 to Amerisourcebergen Drug Corp for 100 capsules of Adderall XR 20 mg on January 9, 2026, with an ultimate completion date of January 12, 2026. This firm fixed-price contract, which carries no set-aside designation, represents a competitively awarded task order under a larger pharmaceutical supply vehicle. Amerisourcebergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor, with its...
- The Defense Logistics Agency awarded a delivery order valued at $7,634.18 to AmerisourceBergen Drug Corp for the supply of Adderall XR 20 mg capsules (100-count units) with a firm fixed-price structure. The contract, awarded on January 9, 2026, has an ultimate completion date of January 12, 2026 and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation, reflecting the contractor's...
- The Defense Logistics Agency awarded a delivery order valued at $1,563.31 to AmerisourceBergen Drug Corp for the supply of Adderall XR 20 mg capsules (100 count) on January 6, 2026, with an ultimate completion date of January 7, 2026. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the awardee's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major...
- The Defense Logistics Agency awarded a delivery order valued at $1,156.08 to AmerisourceBergen Drug Corp for Adderall XR 20 mg capsules (100-count units) on January 8, 2026, with an ultimate completion date of January 9, 2026. This firm fixed-price contract was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order valued at $1,488.69 to AmerisourceBergen Drug Corp for the supply of Adderall XR 20 mg capsules (100-count) on January 14, 2026, with an ultimate completion date of January 15, 2026. This firm fixed-price delivery order is not associated with a set-aside designation and represents a competitive award to the pharmaceutical distributor. The contract is being performed at the awardee's facility in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,878.57 to AmerisourceBergen Drug Corp for the supply of Adderall XR 20 mg capsules (100 count) on January 26, 2026, with a completion date of January 27, 2026. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,290.28 to AmerisourceBergen Drug Corp for the supply of Adderall XR 10 mg capsules (100-count units) on January 6, 2026, with an ultimate completion date of January 7, 2026. This contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $3,631.72 to AmerisourceBergen Drug Corp for the supply of Adderall XR 30 mg capsules (100-count units) on October 27, 2025, with an ultimate completion date of October 28, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $1,382.66 to AmerisourceBergen Drug Corp for 100 capsules of Adderall XR 20 mg on January 8, 2026, with a completion date of January 9, 2026. This non-set-aside order was competitively awarded on a firm fixed-price basis for delivery to the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical...
- SPE2DR25D3016Indefinite Delivery Contract
- SPE2DR25D3016-SPE2DR26FG3ZBDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,347.39 to AmerisourceBergen Drug Corp for the supply of Adderall XR 20 mg capsules (100-count units) on January 29, 2026, with completion scheduled for January 30, 2026. This firm fixed-price delivery order was issued without a set-aside designation, meaning it was competitively awarded. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a task order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. AmerisourceBergen, a subsidiary of parent company Cencora, Inc., serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems. The IDC vehicle enables the company to supply a comprehensive range of pharmaceutical and medical products—including specialty medications, brand-name and generic drugs, vaccines, and medical supplies—to the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 1/28/26 |